Regenerative Medicine Foundation
  • Leadership
  • What We Do
    • Our Event History
    • Policy
    • Advocacy
    • Education & Outreach
  • Events
    • Upcoming Events
    • Past Events
      • World Stem Cell Summit
      • Regenerative Medicine and Stem Cell Action Awards
      • Regenerative Medicine Essentials
      • The “Art of Science” Inspires Students
      • Exploring Public Policy: Regenerative Medicine and Cell Therapies
      • Congressional Briefings
      • World Stem Cell Summit – CHINA
  • Membership/Register
    • Membership
    • Donate
    • Amazon SMILE
  • News
    • News
    • Portraits of Hope
    • Video
    • Video Chats
  • Contact
Select Page
Why we need to modernize Informed Consent

Why we need to modernize Informed Consent

by Admin | Jun 12, 2017 | Bioethics, News & Opinions, Policy

I just spent a week at Wake Forest University Institute for Regenerative Medicine. I enjoyed the experience of being immersed in all things tissue-regeneration, bio-printing, scaffold development, and, especially, the unique collaboration model they have with private...
Time for a national registry for all regenerative cell therapies

Time for a national registry for all regenerative cell therapies

by Bernard Siegel | May 25, 2017 | News & Opinions, Policy

In December 2015, the Bipartisan Policy Center –a Washington, D.C. nonprofit think-tank– published a seminal paper entitled Advancing Regenerative Cellular Therapy -Medical Innovation Healthier Americans. This Report provided information about the nature of cell...
A Story For Science: Call to Action, or Currency?

A Story For Science: Call to Action, or Currency?

by Admin | Apr 24, 2017 | News & Opinions, Policy

Everybody loves a good story. It doesn’t really matter if it’s true or false or somewhere in between. For stories, the truth is found in the telling – in the narrative. When we hear a story, we’re as much captured by the way it’s told, the meaning behind the...
Stem cell clinics in the legal crosshairs

Stem cell clinics in the legal crosshairs

by Bernard Siegel | Apr 12, 2017 | News & Opinions, Policy

Columnist Mitchell Hiltzik savaged the La Jolla-based StemGenix Medical Center “The stem cell therapies offered by La Jolla clinic aren’t FDA approved, may not work- and cost $15,000” reads the title of his piece on the LA Times. StemGenix is the subject of a federal...
Welcome to the Disquieting Era of Sheefs

Welcome to the Disquieting Era of Sheefs

by Bernard Siegel | Apr 10, 2017 | Bioethics, News & Opinions, Policy

Sheef /ʃiːf/ noun acronym. Synthetic Human Entity with Embryo-like Features.  “Change is avalanching upon our heads and most people are grotesquely unprepared to cope with it.” Alvin Toffler (1970)- Future Shock Stem cell engineering has leaped forward so fast that...
CIRM’s Translating Center and Pitching Machine Seek to Speed Up Clinical Trials in the US

CIRM’s Translating Center and Pitching Machine Seek to Speed Up Clinical Trials in the US

by Admin | Nov 10, 2016 | News & Opinions, Policy

The California Institute for Regenerative Medicine (CIRM) is launching  the CIRM Translating Center (TC), the first center in the world designed specifically to overcome the unique challenge of manufacturing, safety testing, and other activities needed to successfully...
Page 1 of 212»

Recent Posts

  • Federal appeals court sends CRISPR-Cas9 patent case back to patent office for reconsideration
  • Embryonic macrophages found to control blood stem cell numbers in bone marrow
  • Biotech Tango dances away from preclinical work to extend cash runway, while Avalo lays out spending options
  • Infant becomes world’s first patient to undergo personalized gene-editing treatment
  • Stem cell model replicates human amniotic sac development past two weeks
Tweets about @WSCSummit